China’s personal income tax revenue soars 13% as top earners face tighter compliance
With China’s personal income tax revenue jumping more than 13 per cent in the first half of the…
China targets new space-based computing network to process data born in orbit
China has unveiled its latest ambitious space-based computing network designed to process satellite data in orbit using AI…
Inside India newsletter: Skyroot rocket puts India alongside U.S., China in private orbital launch
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India” —…
Chinese scientists decode M87 black hole’s radiation secrets
Chinese scientists have taken a crucial step from “seeing” to “reading” a black hole, unveiling the first spatially…
China discloses rare metal that powers its unique spy satellite the US cannot build
A new study in China’s Journal of Microwaves has disclosed the technology behind the world’s only geosynchronous radar…
China Wants to Slam a Spacecraft Into an Asteroid at Mach 26
Following the success of NASA’s DART mission, Chinese researchers are planning a new planetary defense test that they…
China’s Consumption Future Will Be Driven By Small Luxuries
Against the backdrop of flat retail sales growth in the first half of 2026, China has set a…
3 Hong Kong art workshops for a creative soulful escape
In the fast-paced urban rhythm of Hong Kong, a variety of surprising handmade art workshops have emerged in…
CNBC Daily Open: Generic problems, AI valuations and earnings on tap
An employee monitors bottles as they move along the drug production line inside the packaging unit at the…
Exclusive | Can the US and its allies break China’s grip on rare earths and AI technology?
The struggle between the US and China over who will lead in artificial intelligence is one of the…
Crawfish soup on Mars? US fears over China’s scientific ambitions raised in Senate hearing
A Chinese researcher’s vision of serving spicy crawfish soup to astronauts on Mars became an unlikely symbol of…
What’s at stake as Beijing beats global peers with first approval of novel therapy
China’s drug regulator has for the first time approved a novel, globally trialled medicine ahead of authorities in…